Charles River
- Market cap
- 14.34B
- P/E (TTM)i
- -62.56
- P/Bi
- 5.05
- EPSi
- -2.91
- Div yieldi
- 0.00%
- 52W posi
- 82%
Anonymous reader poll. Unscientific, not investment advice.
About Charles River
Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The Research Models and Services segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The Discovery and Safety Assessment segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.
- Founded
- 1947
- CEO
- Ms. Birgit Girshick
- Employees
- 19,700
- Headquarters
- Wilmington, Massachusetts, United States of America
- Fiscal year end
- 01-02
- Website
- criver.com
Company profile
- Exchange
- US
- Symbol
- CRL
- Market-cap rank
- #1174
- Listing date
- 1970-01-01
- Market cap
- 14.34B
- Float cap
- 14.17B
- Shares out
- 47.74M
- Float shares
- 47.20M
Sectors & themes
Quote time 2026-10-08 07:05:05 · For reference only, not investment advice and not tailored to your situation.